share_log

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-UBS Group AG directly and on behalf of certain subsidiaries.(8.91%)

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-UBS Group AG directly and on behalf of certain subsidiaries.(8.91%)

Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-UBS Group AG directly and on behalf of certain subsidiaries.(8.91%)
美股sec公告 ·  02/06 10:42
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息